<table cellpadding="0pt" cellspacing="0pt" id="_RefID0EMTAI" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 4: Clinically Relevant Interactions Affecting Omeprazole When Co-Administered with Other Drugs</caption>
<col width="16%"></col>
<col width="84%"></col>
<tbody>
<tr>
<td colspan="2" stylecode="Rrule Botrule Lrule Toprule " valign="top">
<paragraph>
<content stylecode="bold">CYP2C19 or CYP3A4 Inducers</content>
<br/>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>
<content stylecode="italics">Clinical Impact:</content>
<br/>
</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>Decreased exposure of omeprazole when used concomitantly with strong inducers <content stylecode="italics">[see Clinical Pharmacology (<linkhtml href="#Section_12.3">12.3</linkhtml>)].</content>
<br/>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>
<content stylecode="italics">Intervention:</content>
<br/>
</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>
<content stylecode="underline">St. John’s Wort, rifampin:</content> Avoid concomitant use with omeprazole <content stylecode="italics">[see Warnings and Precautions (<linkhtml href="#Section_5.16">5.9</linkhtml>)].</content>
<br/>
<content stylecode="underline">Ritonavir-containing products:</content> see prescribing information for specific drugs.<br/>
</paragraph>
</td>
</tr>
<tr>
<td colspan="2" stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>
<content stylecode="bold">CYP2C19 or CYP3A4 Inhibitors</content>
<br/>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>
<content stylecode="italics">Clinical Impact:</content>
<br/>
</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>Increased exposure of omeprazole <content stylecode="italics">[see Clinical Pharmacology (<linkhtml href="#Section_12.3">12.3</linkhtml>)].</content>
<br/>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule Lrule " valign="top">
<paragraph>
<content stylecode="italics">Intervention:</content>
<br/>
</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>
<content stylecode="underline">Voriconazole:</content> Dose adjustment of omeprazole is not normally required. However, in patients with Zollinger-Ellison syndrome, who may require higher doses, dose adjustment may be considered.<br/> <br/>See prescribing information for voriconazole.<br/>
</paragraph>
</td>
</tr>
</tbody>
</table>